Citation: B. Bachand et al., Synthesis and structure-activity relationship of potent bicyclic lactam thrombin inhibitors, BIOORG MED, 9(7), 1999, pp. 913-918
Authors:
Plummer, JS
Berryman, KA
Cai, CM
Cody, WL
DiMaio, J
Doherty, AM
Eaton, S
Edmunds, JJ
Holland, DR
Lafleur, D
Levesque, S
Narasimhan, LS
Rubin, JR
Rapundalo, T
Siddiqui, MA
Susser, A
St-Denis, Y
Winocour, P
Citation: Js. Plummer et al., Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1 ' modifications, BIOORG MED, 9(6), 1999, pp. 835-840
Citation: L. Leblond et al., Insertion of the Asp-Ser/Phe sequence in the P ' position of hirutonin provides molecules having both antithrombin and disintegrin activity, THROMB RES, 93(4), 1999, pp. 171-181
Authors:
Plummer, JS
Berryman, KA
Cai, C
Cody, WL
DiMaio, J
Doherty, AM
Edmunds, JJ
He, JX
Holland, DR
Levesque, S
Kent, DR
Narasimhan, LS
Rubin, JR
Rapundalo, ST
Siddiqui, MA
Susser, AJ
St-Denis, Y
Winocour, PD
Citation: Js. Plummer et al., Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications, BIOORG MED, 8(23), 1998, pp. 3409-3414
Authors:
St-Denis, Y
Augelli-Szafran, CE
Bachand, B
Berryman, KA
DiMaio, J
Doherty, AM
Edmunds, JJ
Leblond, L
Levesque, S
Narasimhan, LS
Penvose-Yi, JR
Rubin, JR
Tarazi, M
Winocour, PD
Siddiqui, MA
Citation: Y. St-denis et al., Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications, BIOORG MED, 8(22), 1998, pp. 3193-3198